Terms ending in 2039
Every in-force patent on F. Hoffmann-La Roche AG's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,639,352 | Benzothiazole Compounds for the Treatment of Autoimmune Diseases In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,043,651 | The Compbody - a Multivalent Target Binder In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,597,772 | Obinutuzumab Treatment of a Dlbcl Patient Subgroup In force · High confidence | Bruker Spatial Biology, Inc. | In force | High confidence | |
| US 11,339,187 | Process for the Preparation of Galnac Oligonucleotide Conjugates In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,624,098 | Treatment of Age-Related Macular Degeneration and Diabetic Macular Edema by Administration of a Bispecific Antibody to VEGF and ANG-2 In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 11,460,361 | Validation Apparatus for Validating a Force Testing Machine, Method of Validating a Force Testing Machine and Method of Measuring Forces In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 11,746,140 | COMPOSITION COMPRISING RECOMBINANT GpIba RECEPTOR PROTEIN In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 12,509,500 | Composition Comprising Recombinant Gpiba Receptor Protein In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 10,968,469 | Proline Hydroxylases as Well as Uses, Methods and Products Involving the Same In force · High confidence | Hoffman-la Roche Inc. | In force | High confidence | |
| US 11,280,756 | Method for Detecting an Interferent Contribution in a Biosensor In force · High confidence | Roche Diabetes Care, Inc. and F. Hoffman-la Roche AG | In force | High confidence | |
| 48 more term ends in 2039 · Pro | |||||
10 of 58 patents shown. Soonest term end first, then patent number.
Pro members see all 58.
10 of these are in force and held by F. Hoffmann-La Roche AG.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.